CYRX
Cryoport, Inc.
CYRX lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink.
EOSE
Eos Energy Enterprises, Inc.
There isn't enough reported data to score EOSE yet.
CYRX Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Under pressure | |
| Weak |
CYRX's revenue is currently healthy, but its profitability, cash flow and balance sheet are under pressure.
EOSE Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
EOSE's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
CYRX PE Valuation
CYRX has no meaningful PE right now: it lost money over the past year.
EOSE PE Valuation
EOSE has no meaningful PE right now: it lost money over the past year.
CYRX Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect CYRX's losses to shrink, with revenue growing.
EOSE Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect EOSE's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
CYRX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.89 | -176% |
| Q2 2026 | -$0.82 | -162% |
| Q1 2026 | $1.43 | +$3.77 |
| Q4 2025 | $1.40 | +$3.89 |
| Q3 2025 | $1.17 | +$4.56 |
| Q2 2025 | $1.33 | +$5.01 |
| Q1 2025 | -$2.34 | +$0.14 |
| Q4 2024 | -$2.49 | -$0.28 |
CYRX has the stronger earnings trend. Trailing diluted EPS is down 176% for CYRX versus EOSE down 224%.
EOSE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2023 | -$2.69 | +$0.85 |
| Q2 2023 | -$3.76 | -$1.00 |
| Q1 2023 | -$3.65 | -$0.86 |
| Q4 2022 | -$3.68 | -$1.32 |
| Q3 2022 | -$3.54 | +$5.19 |
EOSE is still losing money, but less than at its worst: $4.55 per share over the past year, against $8.73 at its worst in late 2021.
CYRX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2M | +14% |
| Q2 2026 | $49M | +7.7% |
| Q1 2026 | $47.8M | +16% |
| Q4 2025 | $45.5M | -24% |
| Q3 2025 | $44.2M | -22% |
| Q2 2025 | $45.5M | -21% |
| Q1 2025 | $41M | -25% |
| Q4 2024 | $59.5M | +4% |
CYRX's revenue is recovering but still below its 2022 peak: $50M last quarter, up 14% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -18% | +4.9 points |
| Q2 2026 | -21% | +0.7 points |
| Q1 2026 | -20% | +3 points |
| Q4 2025 | -22% | +1.3 points |
| Q3 2025 | -22% | +6.5 points |
| Q2 2025 | -21% | +116 points |
| Q1 2025 | -23% | +16 points |
| Q4 2024 | -23% | +99 points |
CYRX has the edge over EOSE on profitability, with a higher operating margin.
EOSE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $82.7M | +171% |
| Q2 2026 | $68.8M | +351% |
| Q1 2026 | $57M | +445% |
| Q4 2025 | $58M | +700% |
| Q3 2025 | $30.5M | +3473% |
| Q2 2025 | $15.2M | +1597% |
| Q1 2025 | $10.5M | +58% |
| Q4 2024 | $7.3M | +9.7% |
EOSE has the edge over CYRX on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -96% | +105 points |
| Q2 2026 | -122% | +297 points |
| Q1 2026 | -139% | +367 points |
| Q4 2025 | -140% | +573 points |
| Q3 2025 | -201% | +6044 points |
| Q2 2025 | -419% | +2815 points |
| Q1 2025 | -506% | +117 points |
| Q4 2024 | -713% | -74 points |
EOSE's operating margin was −96% last quarter, up 105 points from the same quarter a year ago, near the top of its range since 2019.
CYRX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$40K | +$1.2M |
| Q2 2026 | -$8M | +$3.7M |
| Q1 2026 | -$6.2M | +$1.3M |
| Q4 2025 | -$4.5M | +$6.2M |
| Q3 2025 | -$1.3M | +$2.5M |
| Q2 2025 | -$11.7M | +$119K |
| Q1 2025 | -$7.5M | -$239K |
| Q4 2024 | -$10.7M | -$1.6M |
CYRX has the edge over EOSE on cash flow, with more consistent year-over-year improvement.
EOSE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$105.1M | -$22.4M |
| Q2 2026 | -$107.4M | -$34.3M |
| Q1 2026 | -$154.8M | -$121M |
| Q4 2025 | -$75.2M | -$19.5M |
| Q3 2025 | -$82.7M | -$28.5M |
| Q2 2025 | -$73.2M | -$40.6M |
| Q1 2025 | -$33.8M | +$10.7M |
| Q4 2024 | -$55.8M | -$10.2M |
EOSE has burned cash in almost every quarter: −$443M over the past year, against −$246M the year before.
CYRX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +211K shares |
| 1 year | +1.1% | +529K shares |
| 3 years | +3.6% | +1.7M shares |
| 5 years | +9.8% | +4.5M shares |
| Available history | +52% | +17.3M shares |
CYRX has the edge over EOSE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $2M |
| Q3 2025 | $3.7M |
| Q4 2022 | $4.6M |
| Q3 2022 | — |
| Q2 2022 | $25M |
| Q1 2022 | $8.3M |
EOSE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +63% | +213M shares |
| 1 year | +161% | +341M shares |
| 3 years | +888% | +497M shares |
EOSE has 553M diluted shares, up 161% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
CYRX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2021 | 110.0x | High |
| Q3 2021 | 24.2x | High |
CYRX's net debt is more than 20 years of its operating earnings (EBITDA).
EOSE Net Leverage
EOSE's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CYRX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 71.7 | Overbought |
| Stochastic | 78.1 | Neutral |
CYRX's weekly RSI is 72 (overbought) and its Stochastic is 78 (neutral).
EOSE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.5 | Neutral |
| Stochastic | 7.4 | Oversold |
EOSE's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
CYRX PE vs Industrials Sector
| Metric | CYRX | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 24x | — |
CYRX has no meaningful PE right now: it lost money over the past year.
EOSE PE vs Industrials Sector
EOSE has no meaningful PE right now: it lost money over the past year.
CYRX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $17.9 | 12% above |
| 20 week MA | $16.7 | 20% above |
| 50 week MA | $13.1 | 53% above |
| 100 week MA | $10.4 | 94% above |
| 200 week MA | $12.4 | 63% above |
CYRX has the edge over EOSE on trend strength, trading above more of its moving averages.
EOSE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.24 | 19% below |
| 20 week MA | $3.28 | 45% below |
| 50 week MA | $7.01 | 74% below |
| 100 week MA | $7.10 | 75% below |
| 200 week MA | $4.53 | 60% below |
EOSE is in a downtrend: it's below all five of its weekly moving averages, and 60% below its 200-week average.
CYRX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $16.2 | $45.8 | +182% |
| 2021 | $45.8 | $59.5 | +30% |
| 2022 | $59.5 | $16.4 | -72% |
| 2023 | $16.4 | $15.5 | -5.5% |
| 2024 | $15.5 | $7.80 | -50% |
| 2025 | $7.80 | $9.66 | +24% |
| 2026 YTD | $9.66 | $20.1 | +108% |
CYRX has the edge over EOSE on returns for 2026, with the stronger performance.
EOSE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.72 | $19.2 | +98% |
| 2021 | $19.2 | $8.57 | -55% |
| 2022 | $8.57 | $1.08 | -87% |
| 2023 | $1.08 | $1.09 | +0.9% |
| 2024 | $1.09 | $5.17 | +374% |
| 2025 | $5.17 | $11.9 | +129% |
| 2026 YTD | $11.9 | $1.81 | -85% |
EOSE's yearly returns have swung widely, from +374% in 2024 to −87% in 2022. It's down 85% so far in 2026.